Etoposide sensitivity of human prostatic cancer cell lines PC-3, DU 145 and LNCaP

Histology and Histopathology

Volumn 14, Issue 1, 1999, Pages 125-134

  Salido, M ^a  

^a UNIVERSITY OF CÁDIZ   (Spain)

Author keywords

Apoptosis; Etoposide; Induction; Prostate cancer

Indexed keywords

ANDROGEN; ANDROSTANOLONE; DNA FRAGMENT; ETOPOSIDE; GYRASE INHIBITOR;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG SENSITIVITY; HUMAN; HUMAN CELL; PROSTATE CANCER;

ANDROGENS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL DIVISION; CELL SURVIVAL; ETOPOSIDE; HUMANS; KINETICS; MALE; NUCLEIC ACID SYNTHESIS INHIBITORS; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0032967460     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Akimoto S., Ohki T., Akakura K., Masai M. and Shimazaki J. (1994). Chemotherapy for endocrine therapy refractory prostate cancer. Cancer Chemother. Pharmacol. 35 (suppl.), S18-22.
2. Amato R.J., Logothetis C.J., Hallinan R., Ro J.Y., Sella A. and Dexeus F.H. (1992). Chemotherapy for small cell carcinoma of prostatic origin. J. Urol. 147, 935-937.
3. Arends M.J. and Wyllie A.H. (1991). Apoptosis: mechanisms and roles in pathology. Int. Rev. Exp. Pathol. 32, 223-251.
4. Barbiero G., Duranti F., Bonelli G., Amenta J.S. and Baccino F.M. (1995). Intracellular ionic variations in the apoptotic death of L cells by inhibitors of cell cycle progression. Exp. Cell Res. 217, 410-418.
5. Bellamy C.O.C., Malcomson R.D.G., Harrison D.J. and Wyllie A.H. (1995). Cell death in health and disease: the biology and regulation of apoptosis. Cancer Biol. 6, 3-16.
6. Berchem G.J., Bosseler M., Sugars L.V.Y., Voeller H.J., Zeitlin S. and Gelmann E.P. (1995). Androgens induce resistance to bcl-2 mediated apoptosis in LNCaP prostate cancer cells. Cancer Res. 55, 735-738.